
Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study
Naismith, Robert T., Wundes, Annette, Ziemssen, Tjalf, Jasinska, Elzbieta, Freedman, Mark S., Lembo, Anthony J., Selmaj, Krzysztof, Bidollari, Ilda, Chen, Hailu, Hanna, Jerome, Leigh-Pemberton, RicharLangue:
english
Journal:
CNS Drugs
DOI:
10.1007/s40263-020-00700-0
Date:
January, 2020
Fichier:
PDF, 1.03 MB
english, 2020